Ketorolac Tromethamine Injection shortage
Ketorolac Tromethamine Injection is currently listed in shortage by the FDA. The FDA lists 25 affected products. The reported reason: Other; Demand increase for the drug; Delay in shipping of the drug. This page was last refreshed from FDA data on Oct 2, 2026.
Ketorolac tromethamine injection has been on the FDA shortage list for over a year, driven by shipping delays and rising demand. The 60 mg/2 mL strength has no available source from makers reporting the shortage, but other manufacturers not reporting a shortage still list all strengths, including 60 mg/2 mL.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Ketorolac Tromethamine Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 22, 2026Currently in shortage25 of 25 products affected.
-
Sep 18, 2026FDA refreshed this shortage record6 products updated.
-
Sep 17, 2026FDA refreshed this shortage record2 products updated.
-
Sep 15, 2026FDA refreshed this shortage record6 products updated.
-
Jul 22, 2026FDA refreshed this shortage record5 products updated.
-
May 15, 2026FDA refreshed this shortage record3 products updated.
-
Jun 6, 2018More presentations reported7 more products added to the shortage.
-
Mar 26, 2018More presentations reported6 more products added to the shortage.
-
Mar 23, 2018First reported to the FDA12 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Alembic Pharmaceuticals 📞 908-393-9604 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | — | Available | — | — |
| Current | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | — | Available | — | — |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | — | Available | — | — |
Manufacturer: Baxter Healthcare 📞 888-229-0001 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | — | Unavailable | Estimated recovery: October 2026 | Demand increase for the drug |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | — | Available | — | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | — | Unavailable | Estimated recovery: TBD | Other |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | — | Unavailable | Next release October 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | — | Available | Check wholesalers for inventory | — |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | — | Unavailable | Estimated recovery: TBD | Other |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | — | Unavailable | Next release October 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
| Current | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | — | Unavailable | Estimated recovery: TBD | Other |
Manufacturer: Gland Pharma Limited 📞 833-291-9645 5 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | — | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Demand increase for the drug |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | — | Available | — | Demand increase for the drug |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | — | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Demand increase for the drug |
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | — | Available | — | — |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | — | Available | — | Demand increase for the drug |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | — | Unavailable | Estimated recovery: TBD | Other |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | — | Unavailable | Estimated recovery: TBD | Other |
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | — | Unavailable | Estimated recovery: TBD | Other |
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | — | Unavailable | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | — | Unavailable | Next Delivery and Estimated Recovery: December 2027 | Other |
| Current | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | — | Unavailable | Next Delivery and Estimated Recovery; December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Manufacturer: Sagent Pharmaceuticals 📞 866-625-1618 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | — | Available | — | — |
| Current | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | — | Unavailable | Estimated recovery: late September 2026, Product in transit | Delay in shipping of the drug |
| Current | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Ketorolac Tromethamine Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Ketorolac Tromethamine Injection? options further down this page.
Why is Ketorolac Tromethamine Injection in shortage?
There are a few different reasons why ketorolac tromethamine injection is on the shortage list, depending on the manufacturer. More people are needing this medication than usual (demand increase), which has put pressure on supplies across the board. On top of that, some manufacturers are dealing with hold-ups at the factory or delays getting their product shipped out. Specifically, Hospira (a Pfizer company) is citing a manufacturing delay for their 15 mg/1 mL, 30 mg/1 mL, and 60 mg/2 mL vials, with expected recovery dates ranging from June 2027 to December 2027. Fresenius Kabi's 30 mg/1 mL vials are held up due to a shipping delay, with the next release expected around October 2026. Sagent's 15 mg/1 mL is also delayed in shipping, with an estimated recovery of late September 2026. Hikma's 15 mg/1 mL and 30 mg/1 mL vials are currently unavailable with no confirmed recovery date yet. Some presentations from Gland Pharma, Sagent, Alembic, and Fresenius Kabi are still listed as available at this time.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Ketorolac Tromethamine Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Ketorolac Tromethamine Injection?
Ketorolac tromethamine injection is currently on the FDA shortage list, and I want to walk you through what that means for the strength you use.
Three strengths still have at least one manufacturer reporting available supply: the 30 mg/1 mL, the 15 mg/1 mL, and one 60 mg/2 mL product. The strength that has no available source right now is the 60 mg/2 mL (30 mg/mL) vial. So if you use any of the first three, there is a reasonable chance your pharmacy can still obtain it.
The FDA-reported reasons here include increased demand, a shipping delay, and "other" causes. This shortage has lasted over a year, and several makers list recovery dates that are still a ways out (some into 2026 or 2027). Even so, 5 of 7 manufacturers on this record still report some supply, so this is not a case of the medicine disappearing entirely.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- If your strength still has supply, ask your pharmacy to order it — they can check wholesalers and other manufacturers.
- The same medicine is made by other companies, so your pharmacy may be able to source one of those, though it may not be in local stock.
- If your exact strength cannot be found, ask your prescriber or pharmacist about options, such as a different strength to make up the dose.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is national data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Ketorolac Tromethamine Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Ketorolac Tromethamine Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 15 mg/mL | Injection, Solution · Intramuscular, Intravenous | Hospira, Inc. | 00409-3793-25 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 30 mg/mL | Injection, Solution · Intramuscular, Intravenous | Hospira, Inc. | 00409-3795-25 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 60 mg/2mL | Injection, Solution · Intramuscular | Hospira, Inc. | 00409-3796-25 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 15 mg/mL | Injection, Solution · Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | 31722-0305-10 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 30 mg/mL | Injection, Solution · Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | 31722-0306-25 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 60 mg/2mL | Injection, Solution · Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | 31722-0307-25 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 30 mg/mL | Injection, Solution · Intramuscular, Intravenous | A-S Medication Solutions | 50090-5428-00 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 15 mg/mL | Injection, Solution · Intramuscular, Intravenous | A-S Medication Solutions | 50090-5609-00 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 60 mg/2mL | Injection · Intramuscular, Intravenous | A-S Medication Solutions | 50090-6772-00 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 15 mg/mL | Injection · Intramuscular, Intravenous | A-S Medication Solutions | 50090-6807-00 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 30 mg/mL | Injection, Solution · Intramuscular, Intravenous | Cardinal Health 107, LLC | 55154-0120-05 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE 15 mg/mL | Injection, Solution · Intramuscular, Intravenous | Cardinal Health 107, LLC | 55154-6960-05 |
Alternative dosage forms of Ketorolac Tromethamine
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Ketorolac Tromethamine 60 mg/2mL | Hospira, | 25 vials | $0.498 | AP | Availability likely |
| Ketorolac Tromethamine 60 mg/2mL | NorthStar | 25 vials | $0.498 | AP | Discontinued |
| Ketorolac Tromethamine 60 mg/2mL | Camber | 25 vials | $0.552 | AP | Availability likely |
| Ketorolac Tromethamine 60 mg/2mL | Alembic | 25 vials | $0.552 | AP | Availability likely |
| Ketorolac Tromethamine 60 mg/2mL | Caplin | 25 vials | $0.552 | AP | Availability likely |
| Ketorolac Tromethamine 60 mg/2mL | GLENMARK | 25 vials | $0.552 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | SOLA | 25 vials | $0.552 | AP | Availability likely |
| ketorolac tromethamine 30 mg/mL | FOSUN | 25 vials | $0.552 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | NorthStar | 25 vials | $0.879 | AP | Discontinued |
| Ketorolac Tromethamine 15 mg/mL | Hospira, | 25 vials | $0.946 | AP | Discontinued |
| Ketorolac Tromethamine 15 mg/mL | Hikma | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | Sagent | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | Camber | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | Alembic | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | Fresenius | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | Caplin | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | GLENMARK | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | SOLA | 25 vials | $0.946 | AP | FDA listed |
| ketorolac tromethamine 15 mg/mL | FOSUN | 25 vials | $0.946 | AP | FDA listed |
| Ketorolac Tromethamine 15 mg/mL | NorthStar | 25 vials | $0.946 | AP | Discontinued |
| Ketorolac Tromethamine 30 mg/mL | Sagent | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Fresenius | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Baxter | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Hospira, | 25 vials | $1.017 | AP | Discontinued |
| Ketorolac Tromethamine 30 mg/mL | Hikma | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Camber | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Alembic | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | Caplin | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | GLENMARK | 25 vials | $1.017 | AP | Availability likely |
| Ketorolac Tromethamine 30 mg/mL | SOLA | 25 vials | $1.017 | AP | Availability likely |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Ketorolac Tromethamine Injection — that fall in the same broad treatment class (nsaids, cyclooxygenase inhibitor type analgesics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other analgesia/addiction shortages
Ketorolac Tromethamine Injection shortage FAQs
Is Ketorolac Tromethamine Injection in shortage?
Why is Ketorolac Tromethamine Injection in shortage?
Which products are affected?
When will Ketorolac Tromethamine Injection be available again?
Can I still get Ketorolac Tromethamine somewhere?
What should I do if I take Ketorolac Tromethamine Injection?
Still have a question about the Ketorolac Tromethamine Injection shortage?
Ask a pharmacist about this shortage →View Ketorolac Tromethamine Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.